NNVC - As Ebola Death Toll Surpasses 930 Within Two Months, NanoViricides Has Applied to the DR Congo Regulatory Agency for Approval for a P
NNVC - As Ebola Death Toll Surpasses 930 Within Two Months, NanoViricides Has Applied to the DR Congo Regulatory Agency for Approval for a Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola
Story updates
12:33:22 PM UTC
SquawkNews
NNVC nanoviricides, Inc - Applied to acorep for approval to begin phase II clinical trial of NV-387 oral gummies as treatment for bundibugyo ebolavirus
NNVC - As Ebola Death Toll Surpasses 930 Within Two Months, NanoViricides Has Applied to the DR Congo Regulatory Agency for Approval for a Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola